Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
802.9 USD | +2.52% | +5.49% | +38.25% |
04:48pm | Eli Lilly: conclusive trial in Crohn's disease | CF |
03:30pm | Central bankers try to reason with investors |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.25% | 705B | |
+32.82% | 583B | |
-3.52% | 364B | |
+20.32% | 332B | |
+5.46% | 291B | |
+17.25% | 238B | |
-3.64% | 210B | |
+10.55% | 209B | |
+8.63% | 169B | |
-1.27% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Jefferies Adjusts Eli Lilly and Co.'s Price Target to $915 From $895, Keeps Buy Rating